USD 0.02
(0.0%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -9.32 Million USD | -10.16% |
2022 | -8.46 Million USD | -29.92% |
2021 | -6.51 Million USD | 50.47% |
2020 | -13.15 Million USD | -1513.21% |
2019 | 931 Thousand USD | 0.0% |
2013 | 3.07 Million USD | -6.48% |
2012 | 3.28 Million USD | 16.55% |
2011 | 2.82 Million USD | 18.58% |
2010 | 2.37 Million USD | 118.16% |
2009 | -13.1 Million USD | -22.28% |
2008 | -10.71 Million USD | -19.94% |
2007 | -8.93 Million USD | -106.95% |
2006 | -4.31 Million USD | 56.15% |
2005 | -9.84 Million USD | -42.24% |
2004 | -6.92 Million USD | -259.11% |
2003 | -1.92 Million USD | -328.59% |
2002 | 843 Thousand USD | 104.56% |
2001 | -18.49 Million USD | -467.27% |
2000 | -3.26 Million USD | 22.38% |
1999 | -4.2 Million USD | -146.15% |
1998 | 9.1 Million USD | -36.36% |
1997 | 14.3 Million USD | 1121.43% |
1996 | -1.4 Million USD | -132.56% |
1995 | 4.3 Million USD | 65.38% |
1994 | 2.6 Million USD | 230.0% |
1993 | -2 Million USD | 78.72% |
1992 | -9.4 Million USD | -113.64% |
1991 | -4.4 Million USD | -51.72% |
1990 | -2.9 Million USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | -9.45 Million USD | 0.0% |
2023 Q3 | - USD | 100.0% |
2023 Q2 | -8.63 Million USD | -0.73% |
2023 Q1 | -8.57 Million USD | 0.0% |
2023 FY | -9.32 Million USD | -10.16% |
2022 FY | -8.46 Million USD | -29.92% |
2022 Q2 | -7.02 Million USD | -8.73% |
2022 Q1 | -6.45 Million USD | 0.0% |
2021 Q1 | -14.89 Million USD | 0.0% |
2021 FY | -6.51 Million USD | 50.47% |
2021 Q2 | -9.61 Million USD | 35.45% |
2020 FY | -13.15 Million USD | -1513.21% |
2019 FY | 931 Thousand USD | 0.0% |
2018 Q3 | 1.81 Million USD | -28.03% |
2018 Q1 | 5.56 Million USD | 0.0% |
2018 Q2 | 2.52 Million USD | -54.66% |
2018 Q4 | 1.24 Million USD | -31.18% |
2017 Q3 | 6.63 Million USD | 0.0% |
2014 Q1 | 2.74 Million USD | 0.0% |
2014 Q2 | 2.4 Million USD | -12.7% |
2014 Q3 | 2.36 Million USD | -1.54% |
2013 Q3 | 2.56 Million USD | -16.55% |
2013 FY | 3.07 Million USD | -6.48% |
2013 Q1 | 3.05 Million USD | -4.95% |
2013 Q2 | 3.07 Million USD | 0.75% |
2012 Q1 | 3.51 Million USD | 13.7% |
2012 FY | 3.28 Million USD | 16.55% |
2012 Q2 | 3.28 Million USD | -6.35% |
2012 Q3 | 3.11 Million USD | -5.32% |
2012 Q4 | 3.21 Million USD | 3.15% |
2011 Q4 | 3.08 Million USD | 9.7% |
2011 Q1 | 3.35 Million USD | -1.44% |
2011 FY | 2.82 Million USD | 18.58% |
2011 Q2 | 2.82 Million USD | -15.82% |
2011 Q3 | 2.81 Million USD | -0.21% |
2010 Q1 | -9.41 Million USD | 20.45% |
2010 FY | 2.37 Million USD | 118.16% |
2010 Q4 | 3.4 Million USD | 49.91% |
2010 Q3 | 2.26 Million USD | -4.67% |
2010 Q2 | 2.37 Million USD | 125.27% |
2009 Q1 | -11.01 Million USD | -82.87% |
2009 Q4 | -11.83 Million USD | -21.44% |
2009 FY | -13.1 Million USD | -22.28% |
2009 Q3 | -9.74 Million USD | 25.6% |
2009 Q2 | -13.1 Million USD | -18.9% |
2008 FY | -10.71 Million USD | -19.94% |
2008 Q4 | -6.02 Million USD | 40.23% |
2008 Q2 | -10.71 Million USD | -3.02% |
2008 Q1 | -10.39 Million USD | -2.21% |
2008 Q3 | -10.08 Million USD | 5.9% |
2007 Q2 | -8.93 Million USD | -42.62% |
2007 Q1 | -6.26 Million USD | 37.06% |
2007 FY | -8.93 Million USD | -106.95% |
2007 Q4 | -10.17 Million USD | -3.06% |
2007 Q3 | -9.87 Million USD | -10.52% |
2006 FY | -4.31 Million USD | 56.15% |
2006 Q1 | -4.09 Million USD | -7.77% |
2006 Q4 | -9.95 Million USD | -142.35% |
2006 Q2 | -4.31 Million USD | -5.5% |
2006 Q3 | -4.1 Million USD | 4.87% |
2005 Q2 | -9.84 Million USD | -20.77% |
2005 FY | -9.84 Million USD | -42.24% |
2005 Q3 | -3.33 Million USD | 66.1% |
2005 Q1 | -8.15 Million USD | -25.02% |
2005 Q4 | -3.79 Million USD | -13.75% |
2004 Q2 | -6.92 Million USD | 2.77% |
2004 Q1 | -7.11 Million USD | -28.0% |
2004 Q4 | -6.51 Million USD | -19.11% |
2004 Q3 | -5.47 Million USD | 20.91% |
2004 FY | -6.92 Million USD | -259.11% |
2003 FY | -1.92 Million USD | -328.59% |
2003 Q1 | -2.35 Million USD | -52.92% |
2003 Q2 | -1.92 Million USD | 18.17% |
2003 Q3 | -3.78 Million USD | -96.57% |
2003 Q4 | -5.56 Million USD | -46.78% |
2002 Q2 | 843 Thousand USD | 111.46% |
2002 Q3 | 17 Thousand USD | -97.98% |
2002 Q4 | -1.54 Million USD | -9158.82% |
2002 FY | 843 Thousand USD | 104.56% |
2002 Q1 | -7.35 Million USD | 57.18% |
2001 FY | -18.49 Million USD | -467.27% |
2001 Q4 | -17.17 Million USD | 20.76% |
2001 Q2 | -18.49 Million USD | -16.59% |
2001 Q3 | -21.68 Million USD | -17.23% |
2001 Q1 | -15.86 Million USD | -9.39% |
2000 Q3 | -6.06 Million USD | -86.01% |
2000 Q2 | -3.26 Million USD | 70.1% |
2000 Q1 | -10.9 Million USD | -22.52% |
2000 Q4 | -14.5 Million USD | -139.13% |
2000 FY | -3.26 Million USD | 22.38% |
1999 FY | -4.2 Million USD | -146.15% |
1999 Q4 | -8.9 Million USD | 34.56% |
1999 Q3 | -13.6 Million USD | -223.81% |
1999 Q2 | -4.2 Million USD | -185.71% |
1999 Q1 | 4.9 Million USD | -50.51% |
1998 Q2 | 9.1 Million USD | -28.91% |
1998 Q3 | 7.2 Million USD | -20.88% |
1998 Q4 | 9.9 Million USD | 37.5% |
1998 FY | 9.1 Million USD | -36.36% |
1998 Q1 | 12.8 Million USD | 0.0% |
1997 Q3 | 15.2 Million USD | 6.29% |
1997 FY | 14.3 Million USD | 1121.43% |
1997 Q1 | 13.1 Million USD | 45.56% |
1997 Q2 | 14.3 Million USD | 9.16% |
1997 Q4 | 12.8 Million USD | -15.79% |
1996 Q4 | 9 Million USD | 32.35% |
1996 Q1 | -7.3 Million USD | -173.74% |
1996 FY | -1.4 Million USD | -132.56% |
1996 Q2 | -1.4 Million USD | 80.82% |
1996 Q3 | 6.8 Million USD | 585.71% |
1995 FY | 4.3 Million USD | 65.38% |
1995 Q1 | 5.4 Million USD | -19.4% |
1995 Q2 | 4.3 Million USD | -20.37% |
1995 Q3 | 3.9 Million USD | -9.3% |
1995 Q4 | 9.9 Million USD | 153.85% |
1994 Q1 | 3.7 Million USD | 511.11% |
1994 FY | 2.6 Million USD | 230.0% |
1994 Q2 | 2.6 Million USD | -29.73% |
1994 Q3 | 4.2 Million USD | 61.54% |
1994 Q4 | 6.7 Million USD | 59.52% |
1993 Q1 | -8 Million USD | 4.76% |
1993 Q2 | -2 Million USD | 75.0% |
1993 Q3 | -1.2 Million USD | 40.0% |
1993 Q4 | -900 Thousand USD | 25.0% |
1993 FY | -2 Million USD | 78.72% |
1992 Q1 | -9.8 Million USD | -75.0% |
1992 Q3 | -8.6 Million USD | 8.51% |
1992 FY | -9.4 Million USD | -113.64% |
1992 Q2 | -9.4 Million USD | 4.08% |
1992 Q4 | -8.4 Million USD | 2.33% |
1991 FY | -4.4 Million USD | -51.72% |
1991 Q2 | -4.4 Million USD | -833.33% |
1991 Q3 | -1 Million USD | 77.27% |
1991 Q4 | -5.6 Million USD | -460.0% |
1991 Q1 | 600 Thousand USD | 0.0% |
1990 Q2 | -2.9 Million USD | 0.0% |
1990 FY | -2.9 Million USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
BioElectronics Corporation | 14.82 Million USD | 162.907% |
Medical Supply International USA, Inc. | 216.6 Thousand USD | 4405.935% |
Polarean Imaging plc | -5.94 Million USD | -56.848% |
Avitar, Inc. | 5.17 Million USD | 280.366% |
CVR Medical Corp. | - USD | Infinity% |
IR-Med Inc. | -606 Thousand USD | -1439.109% |
AVITA Medical, Inc. | -26.23 Million USD | 64.444% |
Manhattan Scientifics, Inc. | -7000.00 USD | -133142.857% |
Össur hf. | 395.08 Million USD | 102.361% |
Zecotek Photonics Inc. | 2.76 Million USD | 437.635% |
QHSLab, Inc. | 1.72 Million USD | 639.142% |
Wellstar International, Inc. | 51.36 Million USD | 118.158% |
Össur hf. | 395.08 Million USD | 102.361% |
Bionovate Technologies Corp | - USD | Infinity% |
EKF Diagnostics Holdings plc | -4.61 Million USD | -102.007% |
Escalon Medical Corp. | 315.68 Thousand USD | 3054.518% |
Aurora Spine Corporation | 1.9 Million USD | 588.925% |
BrainsWay Ltd. | -10.32 Million USD | 9.622% |
Lattice Biologics Ltd. | - USD | Infinity% |
NewCardio, Inc. | 2.41 Million USD | 486.207% |
Hamilton Thorne Ltd. | 18.12 Million USD | 151.456% |
Vivos Inc. | -1.59 Million USD | -485.761% |
MicroPort Scientific Corporation | 673.58 Million USD | 101.385% |
Kelyniam Global, Inc. | 487.33 Thousand USD | 2013.886% |
REMSleep Holdings, Inc. | -540.98 Thousand USD | -1624.074% |
CYduct Diagnostics, Inc. | 640.19 Thousand USD | 1556.895% |
Nanomix Corporation | 11.38 Million USD | 181.894% |
Theraclion SA | -5.86 Million EUR | -59.041% |
Lifeline Biotechnologies, Inc. | - USD | Infinity% |
Wellness Center USA, Inc. | 3.98 Million USD | 334.024% |
Positron Corporation | 1.68 Million USD | 652.914% |
Rafina Innovations Inc. | - USD | Infinity% |
Electromedical Technologies, Inc. | 1.61 Million USD | 679.014% |
Lombard Medical, Inc. | 11.49 Million USD | 181.14% |
ALR Technologies Inc. | 19.14 Million USD | 148.709% |
Stratec SE | 119.12 Million USD | 107.83% |
Vycor Medical, Inc. | 1.05 Million USD | 985.791% |
Heart Tronics, Inc. | 54.99 Thousand USD | 17059.724% |
Nu-Med Plus, Inc. | 93.19 Thousand USD | 10108.155% |
Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | 32.351% |
SANUWAVE Health, Inc. | 30.14 Million USD | 130.938% |
VMS Rehab Systems, Inc. | 133.52 USD | 6985570.342% |
Guided Therapeutics, Inc. | 1.46 Million USD | 735.788% |
Ingen Technologies, Inc. | 630.91 Thousand USD | 1578.32% |
Odyssey Group International, Inc. | 2.1 Million USD | 542.5% |
ECGI Holdings, Inc. | 3.17 Million USD | 394.112% |
Capital Group Holdings, Inc. | -3508.00 USD | -265777.993% |
ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | 3651.546% |
Urologix, Inc. | 4.61 Million USD | 302.102% |
Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | 321.574% |
Nexeon MedSystems Inc. | 3.33 Million USD | 379.985% |
SS Innovations International, Inc. | 1.18 Million USD | 886.86% |
Qualis Innovations, Inc. | 6671.00 USD | 139914.121% |
Smith & Nephew plc | 2.77 Billion USD | 100.336% |
NIOX Group Plc | -23.93 Million USD | 61.028% |
Fuse Medical, Inc. | 1.75 Million USD | 631.303% |
Broncus Holding Corporation | -81.42 Million USD | 88.545% |
Brain Scientific Inc. | 2.11 Million USD | 540.832% |
Pressure BioSciences, Inc. | 22.67 Million USD | 141.13% |
Health Logic Interactive Inc. | 39.55 Thousand USD | 23678.633% |